Featured
SmallCapsDaily Featured Companies
-
Pasithea Therapeutics: An Emerging Biotech Player With An Immediate Revenue Generation Upside
Investing in development stage biotechnology companies can be scary. For months together, these companies do not have revenues and require…
Read More » -
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants (eg: marijuana and hemp). It’s…
Read More » -
Pacific Ventures Group: A High-Potential Food Processing Gem With A D2C Twist
Food and beverages is a sector that is being viewed by investors with a lot of skepticism given the inflationary…
Read More » -
G Medical Innovations: The Perfect Combination of High Growth and Profitability in One Company
On average healthcare takes up about 10% of a country’s GDP and in the USA, it takes up more than…
Read More » -
Pond Technologies: A True Pioneer In Algae-Based Green Technologies
With increased industrial activity over the past decades resulting in a significant impact on the environment, the abatement of carbon…
Read More » -
GROM Primed And Ready As Kids Return to the Classroom
The world has been in and out of some form of lock-down for well over a year now as each…
Read More » -
Quipt Home Medical Corp: The Deeply Undervalued Home Medical Company Helping Create a Safer Post Pandemic World
Quipt Home Medical is a leader in providing clinical respiratory equipment including BiPAP and CPAP machines, oxygen concentrators, sleep apnea…
Read More » -
AgriFORCE: The Ag-Tech Company Disrupting the Outdated Agriculture Industry
To just meet the demand for food the global agriculture industry is going to have to produce 50% more food…
Read More » -
Infobird Taps Into $22B Market With Genius Addition To The Company’s SaaS Product Portfolio
We have extensively covered Chinese SaaS (software as a service) player, Infobird Co. Ltd. (NASDAQ:IFBD) in the past. The company…
Read More » -
Massive Breakthrough for Young Biotech Company Longeveron, Shown in Promising Phase 2b Trial Results
Young and dynamic biotech company Longeveron (Nasdaq:LGVN) announced topline results of their Phase 2b study of Lomecel-B for aging frailty,…
Read More »